Company intelligence / Profile preview

U-Systems

Sunnyvale, California, United Statesusystems.com ↗

Ownership: Private
Development stage: Other

Overview

U‑Systems developed the somo•v Automated Breast Ultrasound system, which received FDA premarket approval for use as an adjunct to mammography for breast cancer screening. The technology was designed to improve early detection of breast cancer in women with dense breasts. The company was acquired by GE Healthcare in 2012[2][3][5].

No ongoing clinical results post-acquisition as a standalone entity.

Therapeutic areas: Oncology
Modalities: Device
Industry: Medical Imaging

Partnerships

None reported outside of parent company relationship.

Beyond the preview

Go deeper on U-Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on U-Systems.

Explore the full profile